REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastoma
-
Published:2024-04
Issue:4
Volume:9
Page:102943
-
ISSN:2059-7029
-
Container-title:ESMO Open
-
language:en
-
Short-container-title:ESMO Open
Author:
Caccese M.ORCID, Desideri I., Villani V., Simonelli M.ORCID, Buglione M., Chiesa S., Franceschi E.ORCID, Gaviani P., Stasi I., Caserta C., Brugnara S., Lolli I., Bennicelli E., Bini P.ORCID, Cuccu A.S., Scoccianti S., Padovan M., Gori S.ORCID, Bonetti A., Giordano P., Pellerino A.ORCID, Gregucci F., Riva N., Cinieri S., Internò V.ORCID, Santoni M., Pernice G., Dealis C., Stievano L., Paiar F., Magni G.ORCID, De Salvo G.L.ORCID, Zagonel V., Lombardi G.ORCID
Reference38 articles.
1. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016-2020;Ostrom;Neuro Oncol,2023 2. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N Engl J Med,2005 3. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood;Weller;Nat Rev Clin Oncol,2021 4. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial;Grothey;Lancet,2013 5. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial;Bruix;Lancet,2017
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. New Insights into Glioblastoma;International Journal of Molecular Sciences;2024-04-07
|
|